Target type: biologicalprocess
The process in which the anatomical structures of the skin are generated and organized. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner, sensitive and vascular dermis (cutis, corium or true skin) composed mostly of connective tissue. [GOC:jl, UBERON:0002097]
Skin morphogenesis is a complex and intricate process that involves the coordinated action of multiple cell types and signaling pathways, ultimately leading to the formation of a functional skin barrier. This process begins during embryonic development and continues throughout postnatal life, with continuous remodeling and regeneration. Here is a detailed description of the key steps involved:
1. **Ectoderm Specification**: The process starts with the specification of the ectoderm, the outermost germ layer of the embryo, which will give rise to the skin and nervous system. Within the ectoderm, a specific region called the surface ectoderm is determined to become the epidermis, the outer layer of the skin.
2. **Epithelial-Mesenchymal Interactions**: Once the surface ectoderm is specified, it interacts with the underlying mesenchyme, derived from the mesoderm germ layer. These interactions are crucial for the formation of the dermis, the inner layer of the skin, and for the organization of the epidermis.
3. **Epidermal Progenitor Cells**: The surface ectoderm forms a single layer of epithelial progenitor cells. These cells proliferate and undergo a series of differentiation events to generate the various cell types of the epidermis.
4. **Formation of Epidermal Layers**: The epidermis develops into multiple layers, each with distinct characteristics and functions:
- **Stratum Basale**: The innermost layer, composed of proliferative basal cells responsible for the constant renewal of the epidermis.
- **Stratum Spinosum**: Above the basal layer, characterized by cells interconnected by desmosomes, providing structural integrity.
- **Stratum Granulosum**: Contains keratohyalin granules, precursors of keratin, and lamellar bodies, which contribute to the formation of the skin barrier.
- **Stratum Lucidum**: A thin layer found only in thick skin (e.g., palms and soles), characterized by flattened, translucent cells.
- **Stratum Corneum**: The outermost layer, composed of dead, keratinized cells, forming a tough and protective barrier against the environment.
5. **Formation of Skin Appendages**: During skin morphogenesis, epidermal cells also differentiate to form skin appendages, including hair follicles, sweat glands, and sebaceous glands. These structures contribute to the functional complexity of the skin.
6. **Dermis Formation**: The underlying mesenchyme differentiates into the dermis, a connective tissue layer containing fibroblasts, blood vessels, nerves, and various extracellular matrix components. The dermis provides structural support and nourishment to the epidermis.
7. **Epithelial-Mesenchymal Interactions During Appendage Formation**: The interactions between the epidermis and the dermis are crucial for the development of skin appendages. For example, the hair follicle is formed by invaginations of the epidermis into the dermis, with signals from the dermis influencing hair follicle morphogenesis.
8. **Skin Barrier Formation**: The outermost layer of the epidermis, the stratum corneum, forms a highly impermeable barrier that prevents water loss and protects the body from external insults. This barrier function is critical for survival and is achieved through the coordinated action of several factors, including:
- **Keratinization**: The process of keratin accumulation and cell death, forming a tough, protective layer.
- **Lipid Synthesis and Deposition**: Lamellar bodies, produced by keratinocytes in the stratum granulosum, release lipids that form a lipid bilayer within the intercellular spaces of the stratum corneum, further strengthening the barrier.
- **Tight Junctions**: These specialized cell junctions between keratinocytes in the upper layers of the epidermis prevent the leakage of water and solutes.
9. **Postnatal Skin Development**: While the basic structure of the skin is established during embryonic development, skin morphogenesis continues throughout life. The skin undergoes constant remodeling and regeneration, with the basal layer cells continuously dividing and differentiating to replace lost cells in the outer layers. This process is regulated by various growth factors and signaling pathways, ensuring the maintenance of skin integrity.
10. **Factors Influencing Skin Morphogenesis**: Skin morphogenesis is influenced by a variety of factors, including genetics, environmental conditions, hormones, and aging. Genetic mutations can lead to skin disorders affecting barrier function or appendage formation. Environmental factors, such as UV radiation and pollutants, can also contribute to skin damage and alter morphogenesis. Hormones, especially sex hormones, influence skin thickness and appendage development. Aging leads to a decline in skin elasticity and regenerative capacity, making the skin more susceptible to damage.
In conclusion, skin morphogenesis is a complex and dynamic process that involves the interplay of multiple cell types and signaling pathways. It is essential for the formation of a functional skin barrier, providing protection and regulating water loss. Understanding skin morphogenesis is crucial for developing strategies to treat skin disorders and enhance skin health.'
"
Protein | Definition | Taxonomy |
---|---|---|
Presenilin-1 | A presenilin-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P49768] | Homo sapiens (human) |
Integrin alpha-2 | An integrin alpha-2 that is encoded in the genome of human. [PRO:CNA, UniProtKB:P17301] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
tocopheroxy radical | tocopheroxy radical: RN given refers to radical ion (1+), (2R-(2R*(4R*,8R*)))-isomer; RN for cpd without isomeric designation not available 12/90 | tocopherol | |
7-amino-4-chloro-3-methoxy-2-benzopyran-1-one | isocoumarins | ||
tarenflurbil | tarenflurbil: R-enantiomer of flurbiprofen but not a COX inhibitor; modulates NF-kB, gamma-secretase, amyloid beta-protein; | flurbiprofen | |
cholanic acid | 5beta-cholanic acids; cholanic acid | ||
arginyl-glycyl-aspartyl-serine | arginyl-glycyl-aspartyl-serine: corresponds to cell attachment site of fibronectin; located near carboxyl-terminal region of alpha-chain of fibrinogen; inhibits platelet aggregation & fibrinogen binding to activated platelets | ||
t0901317 | T0901317: an LXRalpha and LXRbeta agonist | ||
n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | DAPT : A dipeptide consisting of alanylphenylglycine derivatised as a 3,5-difluorophenylacetamide at the amino terminal and a tert-butyl ester at the carboxy terminal. A gamma-secretase inhibitor. | carboxylic ester; difluorobenzene; dipeptide; tert-butyl ester | EC 3.4.23.46 (memapsin 2) inhibitor |
sulindac sulfide | sulindac sulfide : An aryl sulfide that is a metabolite of sulindac. A non-steroidal anti-inflammatory drug, which also has anticancer activity. sulindac sulfide: sulfated analog of indomethacin & inhibitor of prostaglandin synthesis in vitro; RN given refers to cpd without isomeric designation; structure given in first source | aryl sulfide; monocarboxylic acid; organofluorine compound | antineoplastic agent; apoptosis inducer; non-steroidal anti-inflammatory drug |
l 685458 | L 685458: a gamma-secretase inhibitor; structure in first source L-685,458 : A peptide and carboxamide that is L-leucyl-L-phenylalaninamide, L-Leu-L-Phe-NH2, which has been acylated on the N-terminus by a Phe-Phe hydroxyethylene dipeptide isotere, 2R-benzyl-5S-tert-butoxycarbonylamino-4R-hydroxy-6-phenylhexanoic acid. Compounds based on the structure of L-685,458 are potent inhibitors of gamma-secretase, which mediates the final catalytic step that generates the amyloid beta-peptide (Abeta), which assembles into the neurotoxic aggregates in the brains of sufferers of Alzheimer's disease. | carbamate ester; monocarboxylic acid amide; peptide; secondary alcohol | EC 3.4.23.46 (memapsin 2) inhibitor; peptidomimetic |
mk 0752 | |||
ly 450139 | peptide | ||
chf 5074 | 1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid: a beta-amyloid(1-42) lowering agent; structure in first source | ||
ly 411575 | dibenzoazepine; difluorobenzene; lactam; secondary alcohol | EC 3.4.23.46 (memapsin 2) inhibitor | |
4-(2-((1r)-1-(((4-chlorophenyl)sulfonyl)-2,5-difluoroanilino)ethyl)-5-fluorophenyl)butanoic acid | sulfonamide | ||
begacestat | |||
e 2012 | |||
mrk 560 | MRK 560: a gamma-secretase inhibitor; MRK-560 is the (cis)-isomer; structure in first source | ||
1, 3-di-(n-carboxybenzoyl-leucyl-leucyl)amino acetone | 1, 3-di-(N-carboxybenzoyl-leucyl-leucyl)amino acetone: structure in first source | ||
pf 3084014 | nirogacestat : A member of the class of imidazoles that is 1H-imidazole substituted by a 1-[(2,2-dimethylpropyl)amino]-2-methylpropan-2-yl group at position 1 and a {N-[(2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]-L-norvalyl}amino group at position 4. It is a gamma-secretase inhibitor whose hydrobromide salt is indicated for adult patients with progressing desmoid tumours who require systemic treatment. nirogacestat: an antineoplastic agent | ||
bms 708163 | BMS 708163: structure in first source | oxadiazole; ring assembly | |
ro 4929097 | dibenzoazepine; dicarboxylic acid diamide; lactam; organofluorine compound | EC 3.4.23.46 (memapsin 2) inhibitor | |
jnj 40418677 | |||
(r)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1h-pyrazolo(4,3-c)quinoline | (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo(4,3-c)quinoline: gamma secretase inhibitor; structure in first source |